Research Article
Thio-substituted derivatives of 4-amino-pyrazolo[3,4-d]pyrimidine-6-thiol as antiproliferative agents
Published Online:12 Jul 2021https://doi.org/10.4155/fmc-2021-0131
Abstract
The current study was designed to identify new compounds as potential antiproliferative drug candidates. Synthesis of heteroaromatic bicyclic and monocyclic derivatives as purine bioisosters was employed. Their antiproliferative activity was studied against U937 cancer cells. The most effective compounds were evaluated for their selectivity against cancer cells, the possible mechanism of cell death, and their interference with DNA replication. Among the synthesized compounds, only three (4b, 4j and 4l) demonstrated a value of IC50 less than 20 μM. However, two of them (4b and 4l) were specific against cancer cells, with 4l presenting high selectivity. The presence of substituted pyrazolo[3,4-d]pyrimidine core is as essential for this activity as the presence of substituents at the thiol function in 6-position.
Graphical abstract
Keywords:
Papers of special note have been highlighted as: • of interest
References
- 1. Purine nucleoside analogs in the therapy of cancer and neuroinflammation. Mol. Inhib. Target. Ther. 1(1), 3–14 (2015). • Interesting review of the use of purine nucleoside analogs as antiproliferative and anti-inflammatory agents.
- 2. . Pyrazolo[3,4-d]pyrimidine based scaffold derivatives targeting kinases as anticancer agents. Futur. J. Pharm. Sci. 2(1), 20–30 (2016). • Article demonstrates a possible mechanistic action of pyrazolo[3,4-d]pyrimidine derivatives.
- 3. Kinase-targeted cancer therapies: progress, challenges and future directions. Mol. Cancer. 17(1), 1–20 (2018).
- 4. Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment. Bioorg. Med. Chem. Lett. 28(21), 3454–3457 (2018).
- 5. Synthesis and biological evaluations of pyrazolo[3,4-d]pyrimidines as cyclin-dependent kinase 2 inhibitors. Eur. J. Med. Chem. 38(5), 525–532 (2003).
- 6. . Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis. J. Enzyme Inhib. Med. Chem. 34(1), 532–546 (2019). • Interesting report showing the action of pyrazolopyrimidines as EGFR/ErbB2 inhibitors.
- 7. Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and structurally simplified analogs. Chemistry and SAR profile as adenosine receptor antagonists. Curr. Top. Med. Chem. 16(28), 3224–3257 (2016).
- 8. . Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17(5), 565–577 (1976).
- 9. Hydroxyethyl starch 130/0.4 binds to neutrophils impairing their chemotaxis through a mac-1 dependent interaction. Int. J. Mol. Sci. 20(4), (2019).
- 10. . Selective cytotoxic activities of two novel synthetic drugs on human breast carcinoma MCF-7 cells. Anticancer Res. 29(8), 2993–2996 (2009).
- 11. . Detection of necrosis by release of lactate dehydrogenase activity. Methods Mol. Biol. 979, 65–70 (2013).
- 12. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists. J. Med. Chem. 39(5), 1164–1171 (1996).
- 13. Structure activity relationship of 4-amino-2-thiopyrimidine derivatives as platelet aggregation inhibitors. Med. Chem. 15(8), 863–872 (2019).
- 14. Design, synthesis, and evaluation of 3,4-disubstituted pyrazole analogues as anti-tumor CDK inhibitors. Bioorg. Med. Chem. Lett. 17(16), 4557–4561 (2007).
- 15. . Cellular responses to Etoposide: cell death despite cell cycle arrest and repair of DNA damage. Apoptosis 15(2), 162–172 (2010).
- 16. Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells. Br. J. Cancer 70(5), 914–921 (1994).
- 17. . Biologically driven synthesis of pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors: an old scaffold as a new tool for medicinal chemistry and chemical biology studies. Chem. Rev. 114(14), 7189–7238 (2014). • This article shows the effect of some pyrazole analogs on cell cycle, compounds that share similarities with some of the derivatives used in the current study.
- 18. . New advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds. Bioorg. Chem. 78, 341–357 (2018). • Important article describing strategies to synthesize pyrazolo[3,4-d]pyrimidine derivatives and biological actions of such derivatives.
- 19. . Pyrazolopyrimide library screening in glioma cells discovers highly potent antiproliferative leads that target the PI3K/mTOR pathway. Bioorg. Med. Chem. 28(1), 115215 (2020). • This work describes a novel pathway, PI3K/mTOR, that can be targeted by pyrazolopyrimidine derivatives.
